Sort
172,184 grants matching “inflammation”
Breast and Other Cancers in the California Teachers Cohort
$2,522,927Leslie Bernstein · Beckman Research Institute/City Of Hope · R01 · FY2012 · CA
Characterization of the cellular and molecular bases of combined immunodeficiencies
$2,521,984Luigi Notarangelo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Subchondral Bone Cavities in Osteoarthritis Pain
$2,521,652Xu Cao · Johns Hopkins University · RF1 · FY2020 · AG
Effects of Periodontal Therapy on Preterm Birth
$2,521,413University Of Minnesota Twin Cities · U01 · FY2002 · DE
Interplay of tumor genomic and immune characteristics and external drivers of health to improve cancer health outcomes
$2,520,895Susan M Chang · University Of California, San Francisco · U54 · FY2025 · CA
Mechanisms of Immune Activation and Disease Progression in Animal Models
$2,520,873Jason Brenchley · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Clinical trial of omalizumab for allergen sensitized and exposed individuals with COPD
$2,520,503Nirupama Putcha · Johns Hopkins University · U01 · FY2024 · AI
Genetic and Cellular Determinants of Arterial Thrombosis
$2,520,364Roy L Silverstein · Cleveland Clinic Lerner Com-Cwru · P50 · FY2007 · HL
Clinical Epidemiology and Pathogenesis of Asymptomatic HSV
$2,520,298Anna Wald · University Of Washington · P01 · FY2016 · AI
Deciphering the Achilles Heel of Cancer Immunotherapy
$2,520,000Alexandra-Chloe Villani · Massachusetts General Hospital · DP2 · FY2019 · CA
NEDD9 and Chromium(VI) Carcinogenesis
$2,518,755Max Costa · New York University School Of Medicine · R01 · FY2025 · ES
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
$2,518,214Christopher K Glass · University Of California, San Diego · P01 · FY2022 · HL
Epigenomic analysis of primary immune cells from young and old animals
$2,517,685Myong-Hee Sung · National Institute On Aging · ZIA · FY2019 · AG
TAS::75 0872::TAS PROTEOMIC CENTERS: MODIFICATION OF CARDIOVASCULAR PROTEINS BY
$2,516,589Catherine E. Costello · Boston University (Charles River Campus) · N01 · FY2012 · HL
Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Diseases
$2,516,567Edward A Fisher · New York University School Of Medicine · P01 · FY2024 · HL
Center for Spatiotemporal Modeling of Cell Signaling
$2,516,527Bridget S Wilson · University Of New Mexico Health Scis Ctr · P50 · FY2017 · GM
Epidemiology of Diabetes Interventions and Complications (EDIC)
$2,515,897Rose A Gubitosi-Klug · Case Western Reserve University · U01 · FY2016 · DK
Molecular and Cellular Determinants of Disease Heterogeneity in COPD
$2,515,856Frank C. Sciurba · University Of Pittsburgh At Pittsburgh · P50 · FY2008 · HL
Changing the Trajectory of Mild Cognitive Impairment with CPAP Treatment of Obstructive Sleep Apnea
$2,514,739Nalaka S Gooneratne · University Of Pennsylvania · R01 · FY2017 · AG
Costimulatory Mechanisms of Autoimmunity
$2,514,298David A. Hafler · Yale University · P01 · FY2025 · AI
Costimulatory Mechanisms of Autoimmunity
$2,514,298David A. Hafler · Yale University · P01 · FY2024 · AI
Excess cardiovascular inflammation in TB and HIV: EXFIN-TB
$2,513,201Gregory P. Bisson · University Of Pennsylvania · R01 · FY2025 · HL
High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC
$2,512,822Yvonne W Wu · University Of California, San Francisco · U01 · FY2017 · NS
High-throughput in vivo genetics for immunotherapy target discovery
$2,512,500Sidi Chen · Yale University · DP2 · FY2018 · CA
HDL Function in Human Disease
$2,512,032Macrae F Linton · Vanderbilt University Medical Center · P01 · FY2024 · HL